Challenges and Enablers in Platform Trial Methodologies - Scorecard - MDSpire

Challenges and Enablers in Platform Trial Methodologies

  • By

  • Stuart McLennan

  • Alexandra Griessbach

  • Sharon Love

  • Christof Manuel Schönenberger

  • Alain Amstutz

  • Lucille Sebastian

  • Dominique Costagliola

  • Inge Christoffer Olsen

  • Corina Silvia Rueegg

  • Matthew R. Sydes

  • Matthias Briel

  • Benjamin Speich

  • April 2, 2026

  • 0 min

Share

Clinical Scorecard: Challenges and Enablers in Platform Trial Methodologies

At a Glance

CategoryDetail
Condition
Key MechanismsPlatform trials allow for multiple interventions to be evaluated simultaneously and new interventions to be added post-initiation, as defined in the source.
Target Population
Care Setting

Key Highlights

  • Include evidence from the source to substantiate claims about resource efficiency.

Guideline-Based Recommendations

Diagnosis

    Management

    • Engage stakeholders early in the planning process to address funding and staffing needs, as highlighted in the source.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Participants in platform trials across various clinical conditions.

        Platform trials can expedite the evaluation of multiple treatments, potentially improving patient outcomes.

        Clinical Best Practices

        • Add specific practices derived from the experiences of the FOCUS4 and STAMPEDE trial teams.

        References

        Original Source(s)

        Challenges and Enablers in Platform Trial Methodologies

        • by Stuart McLennan, Alexandra Griessbach, Sharon Love, Christof Manuel Schönenberger, Alain Amstutz, Lucille Sebastian, Dominique Costagliola, Inge Christoffer Olsen, Corina Silvia Rueegg, Matthew R. Sydes, Matthias Briel, Benjamin Speich

        • April 2, 2026

        Related Content

        Determinants of COVID-19 Vaccination Rates Among Residents of Kwahu South Municipality in Ghana's Eastern Region

        Assessment of Seroprevalence, Immune Response Patterns, and COVID-19 Incidence Following CoronaVac Vaccination in a Fully Vaccinated Small Municipality in Northeast Brazil: A Population-Based Surveillance Analysis

        Trends in Tuberculosis Notifications and Treatment Results in Bangladesh: Insights from National TB Program Data (2019–2021)